Annual Total Debt
$2.12 M
-$591.00 K-21.80%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual total debt is $2.12 million, with the most recent change of -$591.00 thousand (-21.80%) on March 31, 2024.
- During the last 3 years, VTGN annual total debt has fallen by -$1.60 million (-42.99%).
- VTGN annual total debt is now -85.14% below its all-time high of $14.26 million, reached on March 31, 2015.
Performance
VTGN Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.79 M
-$196.00 K-9.85%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly total debt is $1.79 million, with the most recent change of -$196.00 thousand (-9.85%) on September 30, 2024.
- Over the past year, VTGN quarterly total debt has stayed the same.
- VTGN quarterly total debt is now -87.42% below its all-time high of $14.26 million, reached on March 31, 2015.
Performance
VTGN Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
VTGN Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.8% | 0.0% |
| 3 y3 years | -43.0% | 0.0% |
| 5 y5 years | +3083.2% | 0.0% |
VTGN Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.0% | at low | -54.9% | at low |
| 5 y | 5-year | -48.2% | +3083.2% | -60.3% | at low |
| alltime | all time | -85.1% | >+9999.0% | -87.4% | -100.0% |
VistaGen Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.79 M(-9.8%) |
| Jun 2024 | - | $1.99 M(-6.1%) |
| Mar 2024 | $2.12 M(-21.8%) | $2.12 M(-6.0%) |
| Dec 2023 | - | $2.25 M(-5.2%) |
| Sep 2023 | - | $2.38 M(-27.5%) |
| Jun 2023 | - | $3.28 M(+21.1%) |
| Mar 2023 | $2.71 M(-10.8%) | $2.71 M(-13.8%) |
| Dec 2022 | - | $3.15 M(-11.8%) |
| Sep 2022 | - | $3.57 M(-10.4%) |
| Jun 2022 | - | $3.98 M(+31.0%) |
| Mar 2022 | $3.04 M(-18.3%) | $3.04 M(-3.3%) |
| Dec 2021 | - | $3.14 M(-11.3%) |
| Sep 2021 | - | $3.54 M(-2.5%) |
| Jun 2021 | - | $3.63 M(-2.3%) |
| Mar 2021 | $3.72 M(-9.1%) | $3.72 M(-4.7%) |
| Dec 2020 | - | $3.90 M(-9.8%) |
| Sep 2020 | - | $4.32 M(-4.2%) |
| Jun 2020 | - | $4.52 M(+10.4%) |
| Mar 2020 | $4.09 M(+6043.8%) | $4.09 M(-2.0%) |
| Dec 2019 | - | $4.18 M(-3.7%) |
| Sep 2019 | - | $4.34 M(-3.4%) |
| Jun 2019 | - | $4.49 M(+6641.6%) |
| Mar 2019 | $66.60 K(+1.2%) | $66.60 K(+12.7%) |
| Dec 2018 | - | $59.10 K(-53.2%) |
| Sep 2018 | - | $126.30 K(-34.4%) |
| Jun 2018 | - | $192.40 K(+192.4%) |
| Mar 2018 | $65.80 K(-4.8%) | $65.80 K(+16.9%) |
| Dec 2017 | - | $56.30 K(-52.4%) |
| Sep 2017 | - | $118.40 K(-33.9%) |
| Jun 2017 | - | $179.20 K(+159.3%) |
| Mar 2017 | $69.10 K(-3.9%) | $69.10 K(+91.4%) |
| Dec 2016 | - | $36.10 K(-49.7%) |
| Sep 2016 | - | $71.70 K(-32.9%) |
| Jun 2016 | - | $106.80 K(+48.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | $71.90 K(-99.5%) | $71.90 K(-31.2%) |
| Dec 2015 | - | $104.50 K(-25.1%) |
| Sep 2015 | - | $139.50 K(-89.9%) |
| Jun 2015 | - | $1.39 M(-90.3%) |
| Mar 2015 | $14.26 M(+106.1%) | $14.26 M(+19.8%) |
| Dec 2014 | - | $11.90 M(+6.6%) |
| Sep 2014 | - | $11.16 M(+29.1%) |
| Jun 2014 | - | $8.65 M(+25.0%) |
| Mar 2014 | $6.92 M(+29.4%) | $6.92 M(+8.4%) |
| Dec 2013 | - | $6.39 M(+7.4%) |
| Sep 2013 | - | $5.95 M(+5.0%) |
| Jun 2013 | - | $5.66 M(+5.9%) |
| Mar 2013 | $5.35 M(+49.8%) | $5.35 M(+1.9%) |
| Dec 2012 | - | $5.25 M(+63.0%) |
| Sep 2012 | - | $3.22 M(-4.6%) |
| Jun 2012 | - | $3.38 M(-5.4%) |
| Mar 2012 | $3.57 M(>+9900.0%) | $3.57 M(+7.8%) |
| Dec 2011 | - | $3.31 M(-48.6%) |
| Sep 2011 | - | $6.44 M(+85.3%) |
| Jun 2011 | - | $3.47 M(>+9900.0%) |
| Mar 2011 | - | $500.00(0.0%) |
| Dec 2010 | $500.00(0.0%) | $500.00(0.0%) |
| Sep 2010 | - | $500.00(0.0%) |
| Jun 2010 | - | $500.00(0.0%) |
| Mar 2010 | - | $500.00(0.0%) |
| Dec 2009 | $500.00(0.0%) | $500.00(0.0%) |
| Sep 2009 | - | $500.00(0.0%) |
| Jun 2009 | - | $500.00(>+9900.0%) |
| Mar 2009 | - | $0.00(-100.0%) |
| Dec 2008 | $500.00 | $500.00(>+9900.0%) |
| Sep 2008 | - | $0.00(-100.0%) |
| Jun 2008 | - | $500.00(0.0%) |
| Mar 2008 | - | $500.00(>+9900.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00 |
FAQ
- What is VistaGen Therapeutics annual total debt?
- What is the all time high annual total debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual total debt year-on-year change?
- What is VistaGen Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly total debt year-on-year change?
What is VistaGen Therapeutics annual total debt?
The current annual total debt of VTGN is $2.12 M
What is the all time high annual total debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual total debt is $14.26 M
What is VistaGen Therapeutics annual total debt year-on-year change?
Over the past year, VTGN annual total debt has changed by -$591.00 K (-21.80%)
What is VistaGen Therapeutics quarterly total debt?
The current quarterly total debt of VTGN is $1.79 M
What is the all time high quarterly total debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly total debt is $14.26 M
What is VistaGen Therapeutics quarterly total debt year-on-year change?
Over the past year, VTGN quarterly total debt has changed by $0.00 (0.00%)